tirzepatide summit trial cardiovascular outcomes Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular In pts wiht HFpEF and

Name: tirzepatide summit trial cardiovascular outcomes Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular In pts wiht HFpEF and
Brand: matisco.be
SKU: 18284958367
Price: 24.22 USD
Availability: InStock
Rating: 4.0459 (23 reviews)

SKU: 18284958367

4.0

USD24.22 USD65.22

Pay in 4 interest-free payments of $6.05 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

In pts wiht HFpEF and obesity, tirzepatide (Mounjaro) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in SUMMIT trial https: t.co 8ZHm4gySiL SUMMIT: Tirzepatide a 'Huge Win' for HFpEF Patients With Obesity JACC #ACC25: A recent #JACC publication on the SUMMIT trial evaluates tirzepatide in patients with #HFpEF, with secondary analyses focusing on (1) cardiac structure and (2) #CKD. https: bit.ly 3EdDCQK Facebook 4th ACC.25 Congress Coverage: Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity, SUMMIT Trial, by Dr. Roudbari, Cardiologist., Stay tuned for more insights from the

Store: matisco.be · Domain: matisco.be

Description

2017 Ingredientes: Acetil L - carnitina N/A: No aplicable Otros ingredientes: Edulcorante (E420i): sorbitol, dextrosa, agente de carga (E460i): celulosa microcristalina, fructooligosacridos, antiaglomerante (E470b): sales magnsicas de cidos grasos, aroma de limn